Literature DB >> 27837184

MRI findings and cognitive functions in a small cohort of myotonic dystrophy type 1: Retrospective analyses.

Arsida Bajrami1, Filiz Azman1, Vildan Yayla1, Sultan Cagirici1, Cahit Keskinkiliç2, Nejla Sozer1.   

Abstract

Myotonic dystrophy type 1 (DM1) is a progressive multisystemic disease with common cognitive deficits and potential brain involvement in addition to the cardinal muscular and systemic symptoms. Impaired mental function associated with nonspecific pathological findings such as white-matter hyperintense lesions (WMHLs), ventricular enlargement and brain atrophy on brain MRI have been previously reported in DM1 patients. While some studies showed correlation of brain morphological changes with neuropsychological and clinical parameters including CTG repeat sizes and disease severity scales in DM1, others failed. The goal of this study was to retrospectively investigate cranial MR abnormalities, predominantly WMHLs, and their effects on clinical and cognitive deficits in a small, phenotypically or genotypically well-characterized cohort of DM1 patients.

Entities:  

Keywords:  Cranial MRI; myotonic dystrophy; white-matter hyperintense lesions

Mesh:

Year:  2016        PMID: 27837184      PMCID: PMC5564333          DOI: 10.1177/1971400916678223

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  22 in total

1.  Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Authors:  Daniel T Franc; Ryan L Muetzel; Paul R Robinson; Craig P Rodriguez; Joline C Dalton; Cameron E Naughton; Bryon A Mueller; Jeffrey R Wozniak; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2012-01-30       Impact factor: 4.296

2.  Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Kelvin O Lim; Laura S Hemmy; John W Day
Journal:  J Neurol Sci       Date:  2014-04-13       Impact factor: 3.181

3.  Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: an MRI and neuropathological study.

Authors:  A Ogata; S Terae; M Fujita; K Tashiro
Journal:  Neuroradiology       Date:  1998-07       Impact factor: 2.804

4.  Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy.

Authors:  S J Huber; J T Kissel; E C Shuttleworth; D W Chakeres; L E Clapp; M A Brogan
Journal:  Arch Neurol       Date:  1989-05

5.  A new rating scale for age-related white matter changes applicable to MRI and CT.

Authors:  L O Wahlund; F Barkhof; F Fazekas; L Bronge; M Augustin; M Sjögren; A Wallin; H Ader; D Leys; L Pantoni; F Pasquier; T Erkinjuntti; P Scheltens
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

6.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

7.  Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).

Authors:  G Meola; V Sansone; D Perani; S Scarone; S Cappa; C Dragoni; E Cattaneo; M Cotelli; C Gobbo; F Fazio; G Siciliano; M Mancuso; E Vitelli; S Zhang; R Krahe; R T Moxley
Journal:  Neuromuscul Disord       Date:  2003-12       Impact factor: 4.296

8.  Specific tau variants in the brains of patients with myotonic dystrophy.

Authors:  P Vermersch; N Sergeant; M M Ruchoux; H Hofmann-Radvanyi; A Wattez; H Petit; P Dwailly; A Delacourte
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910

9.  Neuropathology does not Correlate with Regional Differences in the Extent of Expansion of CTG Repeats in the Brain with Myotonic Dystrophy Type 1.

Authors:  Kyoko Itoh; Maki Mitani; Kunihiko Kawamoto; Naonobu Futamura; Itaru Funakawa; Kenji Jinnai; Shinji Fushiki
Journal:  Acta Histochem Cytochem       Date:  2010-12-18       Impact factor: 1.938

10.  The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.

Authors:  Martina Minnerop; Bernd Weber; Jan-Christoph Schoene-Bake; Sandra Roeske; Sandra Mirbach; Christian Anspach; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Thomas Klockgether; Cornelia Kornblum
Journal:  Brain       Date:  2011-11-29       Impact factor: 13.501

View more
  6 in total

1.  Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances.

Authors:  T Cabada; J Díaz; M Iridoy; P López; I Jericó; P Lecumberri; B Remirez; R Seijas; M Gomez
Journal:  Neuroradiology       Date:  2020-11-25       Impact factor: 2.804

2.  Event-related potentials using the auditory novel paradigm in patients with myotonic dystrophy.

Authors:  Shugo Suwazono; Hiroshi Arao; Yukihiko Ueda; Shino Maedou
Journal:  J Neurol       Date:  2021-02-20       Impact factor: 4.849

Review 3.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

4.  Cognitive impairment in neuromuscular diseases: A systematic review.

Authors:  Marco Orsini; Ana Carolina; Andorinho de F Ferreira; Anna Carolina Damm de Assis; Thais Magalhães; Silmar Teixeira; Victor Hugo Bastos; Victor Marinho; Thomaz Oliveira; Rossano Fiorelli; Acary Bulle Oliveira; Marcos R G de Freitas
Journal:  Neurol Int       Date:  2018-07-04

5.  Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

Authors:  Edward Callus; Enrico G Bertoldo; Maria Beretta; Sara Boveri; Rosanna Cardani; Barbara Fossati; Elisa Brigonzi; Giovanni Meola
Journal:  Front Neurol       Date:  2018-09-19       Impact factor: 4.003

Review 6.  Current Progress in CNS Imaging of Myotonic Dystrophy.

Authors:  Martina Minnerop; Carla Gliem; Cornelia Kornblum
Journal:  Front Neurol       Date:  2018-08-21       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.